Belkyra
Belkyra Double Chin Treatment – Is It Effective?
May 13, 2025
Facial fat is organized into distinct compartments, such as the nasolabial, cheek, and jowl fat pads, which collectively shape facial contour and volume. As aging occurs, these fat compartments undergo changes—especially in the lower face—leading to volume loss, sagging, and submental fullness (double chin).
In recent years, non-surgical approaches have emerged to target this concern, offering alternatives to traditional surgical methods. Among these, Belkyra has gained prominence as an injectable treatment specifically designed to reduce fat beneath the chin by targeting fat cells directly. Its minimally invasive nature makes it an attractive option for those seeking facial contouring without surgery.
This article examines the mechanism of action behind Belkyra, its clinical benefits, and the scientific evidence that supports its effectiveness in treating submental fullness.
Key Takeaways
- Belkyra uses synthetic deoxycholic acid to break down and permanently eliminate fat cells in the submental area (under the chin).
- Treatment typically requires 2 to 4 sessions spaced 4–6 weeks apart, with each session lasting about 20–30 minutes.
- Common side effects include swelling, bruising, and tenderness, which generally resolve within a few days.
- Clinical studies and before-and-after photos confirm its effectiveness in reducing double chin and improving jawline contour.
- Ideal candidates are adults with moderate submental fat, good skin elasticity, and a stable body weight.
- Belkyra offers a non-surgical alternative to liposuction and cryolipolysis, with gradual, natural-looking results and no downtime.
- Patient selection, proper technique, and adherence to treatment protocols are critical for optimal, long-lasting outcomes.
Book a Meeting
About: Trusted by over 2,000+ global clients since 2014, Maylips has become a leading supplier of cosmetic, skincare, and orthopedic products for medical and aesthetic professionals. Maylips offers a wide range of authentic brand-name products at competitive wholesale prices, sourced from around the world. If you’re looking to buy Belkyra online, contact our sales team for guidance.
Mechanism of Action – How Belkyra Targets Submental Fat
Belkyra contains synthetic deoxycholic acid, a molecule naturally found in the body that aids in breaking down and absorbing dietary fat. When injected into the submental fat (the area under the chin), it disrupts the membranes of fat cells, causing them to rupture. Over subsequent weeks, the body gradually metabolizes and clears these dead fat cells through the lymphatic system.
This localized process confines the effect to the treated area without systemic involvement. Once destroyed, these fat cells do not regenerate, making the results permanent as long as the patient maintains a stable weight. Belkyra offers a precise, controlled method to contour the chin area without the risks and recovery time associated with surgery.
Injection Technique and Treatment Protocol
Belkyra treatments follow a standardized and precise protocol designed to maximize safety and efficacy:
- Marking the Treatment Area: The provider outlines the submental region to target excess fat.
- Anesthesia Application: A topical anesthetic or ice pack minimizes discomfort.
- Injection Process: 20–50 small injections are administered in a grid-like pattern using a fine needle.
- Session Duration: Each treatment lasts approximately 20–30 minutes.
- Treatment Frequency: Most patients require 2–4 sessions, spaced 4–6 weeks apart.
- Post-Treatment Effects: Temporary swelling, bruising, and tenderness are common but resolve in a few days.
This protocol is designed to balance patient comfort with optimal, lasting results.
Clinical Evidence – Assessing Belkyra’s Effectiveness
A range of clinical studies confirms Belkyra’s ability to reduce submental fat through the targeted action of synthetic deoxycholic acid injections. For example, a postmarketing surveillance study conducted in Korea demonstrated both the safety and efficacy of Belkyra, with patients showing significant fat reduction and expressing high satisfaction levels.
Additional research has focused on healthcare professionals’ comprehension of the injection protocol, which is crucial to ensuring consistent, safe administration. Overall, the evidence highlights minimal downtime and progressive improvements over multiple sessions.
The visible changes documented in Belkyra before and after photos across diverse patient profiles underscore its role as a reliable non-surgical alternative for jawline contouring and submental fat reduction.
Metrics: Fat Volume Reduction and Patient-Reported Outcomes
Studies reveal that patients receiving 2 to 4 treatment sessions often experience meaningful contour improvements. MRI scans confirm a measurable reduction in submental fat thickness, while patient-reported outcomes emphasize high satisfaction, particularly among individuals with moderate submental fullness.
The research further supports Belkyra’s capacity to provide permanent fat cell destruction when the treatment course is completed. Additionally, minimal downtime and gradual, natural-looking results increase the treatment’s popularity.
Patient Selection – Identifying Ideal Candidates for Belkyra
Belkyra’s effectiveness is maximized when administered to appropriately selected patients. The ideal candidates generally meet the following criteria:
- Adults with moderate to significant submental fat contributing to the appearance of a double chin.
- Individuals who are close to their ideal body weight, as Belkyra is not designed as a weight-loss solution.
- Patients with good skin elasticity, allowing for natural skin retraction following fat reduction.
- Those seeking a minimally invasive treatment with little to no recovery time.
Patients with excessive skin laxity or very large fat volumes may not achieve optimal results with Belkyra alone and might benefit more from surgical procedures or combined therapies.
Contraindications and Factors Affecting Treatment Success
Belkyra should not be used in patients with:
- Active skin infections at or near the injection site.
- A history of neck surgery or significant scarring in the submental area.
- Known allergies to deoxycholic acid or any components of the formulation.
- Difficulty swallowing or facial nerve disorders.
Additional factors such as poor skin tone, large fat volume, or unrealistic expectations can limit treatment effectiveness. Hence, a thorough evaluation by a qualified provider is essential to ensure safety and optimize outcomes.
Comparative Analysis – Belkyra vs. Alternative Treatments
When considering submental fat reduction, it is important to compare Belkyra with other options like liposuction and cryolipolysis (CoolSculpting).
Liposuction vs. Belkyra
Liposuction offers immediate and more dramatic fat removal but is a surgical procedure requiring anesthesia, incisions, and recovery time. It suits patients seeking rapid, large-volume fat reduction.
Belkyra, by contrast, is non-surgical with no downtime. It delivers gradual results over several treatment sessions, ideal for those preferring a less invasive approach.
Cryolipolysis vs. Belkyra
Cryolipolysis uses controlled cooling to destroy fat cells and typically requires fewer sessions. However, it may lack the precision contouring Belkyra provides. As an injectable, Belkyra allows targeted sculpting especially in the submental region, resulting in refined jawline definition.
Belkyra’s Advantages & Limitations
- Non-surgical and FDA-approved
- Permanent fat destruction with completed treatments
- No anesthesia or incisions
- Gradual, natural-looking results
However, Belkyra also has the following drawbacks:
- Swelling and bruising for several days post-treatment
- Multiple sessions required
- Less effective for large fat volumes
- Higher per-session cost than some alternatives
Conclusion
Belkyra is a clinically validated, non-surgical treatment option for reducing moderate submental fat, with high rates of patient satisfaction. It is most effective in patients with good skin tone and realistic expectations. Success depends on careful patient selection and administration by experienced providers. Offering a minimally invasive alternative to surgery, Belkyra delivers long-lasting results for individuals seeking subtle yet effective jawline contouring without downtime.
FAQs
1. How many Belkyra treatments are usually needed?
For optimal results, most patients need 2 to 4 sessions spaced about a month apart, but some may require up to 6.
2. Is Belkyra treatment painful?
Mild discomfort is common, but numbing agents or ice minimize pain during the procedure.
3. How long does it take to see results?
Visible changes can begin as early as 4 weeks, with full results developing over 8 to 12 weeks.
4. Are Belkyra results permanent?
Yes, once fat cells are destroyed, they do not return. Maintaining a stable weight helps preserve results.
5. What are the common side effects after treatment?
Swelling, bruising, numbness, and tenderness are common and usually resolve within a few days to a week.
6. Can Belkyra be used in areas other than the chin?
Currently, Belkyra is FDA-approved only for submental fat and should not be used elsewhere off-label without expert guidance.
7. Who should avoid Belkyra treatment?
People with infection, prior neck surgery, or poor skin quality may not be suitable candidates and should consult a specialist.
Talk with our sales representative.
Book a Meeting
References
Coleman SR, Mazzola RF, Pu LLQ, eds. Chapter 49 ANATOMY AND HISTOLOGY OF THE FAT COMPARTMENTS OF THE FACE. Fat Injection. Published online 2018. doi:https://doi.org/10.1055/b-0038-149585
Injection Lipolysis | Nonsurgical Fat Reduction. American Society of Plastic Surgeons. https://www.plasticsurgery.org/cosmetic-procedures/nonsurgical-fat-reduction/injection-lipolysis
